Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial
Conrad, C, Lymp, J, Thompson, V, Dunn, C, Davies, Z, Chatfield, B, Nichols, D, Clancy, J, Vender, R, Egan, M.E, Quittell, L, Michelson, P, Antony, V, Spahr, J, Rubenstein, R.C, Moss, R.B, Herzenberg, L.A, Goss, C.H, Tirouvanziam, R
Published in Journal of cystic fibrosis (01.03.2015)
Published in Journal of cystic fibrosis (01.03.2015)
Get full text
Journal Article
WS23.6 Ivacaftor treatment in patients with cystic fibrosis who have an R117H-CFTR mutation, the KONDUCT study
Moss, R.B, Flume, P.A, Elborn, J.S, Cooke, J, Rowe, S.M, McColley, S.A, Rubenstein, R.C, Higgins, M
Published in Journal of cystic fibrosis (01.06.2014)
Published in Journal of cystic fibrosis (01.06.2014)
Get full text
Journal Article